OTUD1 and non-small cell lung carcinoma: The evidence provided by our study highlighted that OTUD1 under-expression occurred in PC-9/ER cells, while its ectopic expression attenuated the resistance of NSCLC cells to erlotinib based on in vitro and in vivo experiments.